These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
403 related items for PubMed ID: 22492468
1. Reversal of endothelial progenitor cell dysfunction in patients with type 2 diabetes using a conditioned medium of human embryonic stem cell-derived endothelial cells. Ho JC, Lai WH, Li MF, Au KW, Yip MC, Wong NL, Ng ES, Lam FF, Siu CW, Tse HF. Diabetes Metab Res Rev; 2012 Jul; 28(5):462-73. PubMed ID: 22492468 [Abstract] [Full Text] [Related]
2. Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties. Smadja DM, d'Audigier C, Bièche I, Evrard S, Mauge L, Dias JV, Labreuche J, Laurendeau I, Marsac B, Dizier B, Wagner-Ballon O, Boisson-Vidal C, Morandi V, Duong-Van-Huyen JP, Bruneval P, Dignat-George F, Emmerich J, Gaussem P. Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):551-9. PubMed ID: 21148423 [Abstract] [Full Text] [Related]
5. Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Cho SW, Moon SH, Lee SH, Kang SW, Kim J, Lim JM, Kim HS, Kim BS, Chung HM. Circulation; 2007 Nov 20; 116(21):2409-19. PubMed ID: 17984381 [Abstract] [Full Text] [Related]
8. Both CD133(+) cells and monocytes provide significant improvement for hindlimb ischemia, although they do not transdifferentiate into endothelial cells. Sanchez-Guijo FM, Oterino E, Barbado MV, Carrancio S, Lopez-Holgado N, Muntion S, Hernandez-Campo P, Sanchez-Abarca LI, Perez-Simon JA, San Miguel JF, Briñon JG, del Cañizo MC. Cell Transplant; 2010 Nov 20; 19(1):103-12. PubMed ID: 19818207 [Abstract] [Full Text] [Related]
13. Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells. Huang PH, Chen CY, Lin CP, Wang CH, Tsai HY, Lo WY, Leu HB, Chen JW, Lin SJ, Chu PH. Arterioscler Thromb Vasc Biol; 2013 Apr 11; 33(4):709-17. PubMed ID: 23413425 [Abstract] [Full Text] [Related]
14. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Nakagami H, Maeda K, Morishita R, Iguchi S, Nishikawa T, Takami Y, Kikuchi Y, Saito Y, Tamai K, Ogihara T, Kaneda Y. Arterioscler Thromb Vasc Biol; 2005 Dec 11; 25(12):2542-7. PubMed ID: 16224047 [Abstract] [Full Text] [Related]
15. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S, Fuchs S, Epstein SE. Circulation; 2004 Mar 30; 109(12):1543-9. PubMed ID: 15023891 [Abstract] [Full Text] [Related]
16. Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization. Goukassian DA, Qin G, Dolan C, Murayama T, Silver M, Curry C, Eaton E, Luedemann C, Ma H, Asahara T, Zak V, Mehta S, Burg A, Thorne T, Kishore R, Losordo DW. Circulation; 2007 Feb 13; 115(6):752-62. PubMed ID: 17261656 [Abstract] [Full Text] [Related]
17. Role of bone morphogenetic protein 2 in the crosstalk between endothelial progenitor cells and mesenchymal stem cells. Raida M, Heymann AC, Günther C, Niederwieser D. Int J Mol Med; 2006 Oct 13; 18(4):735-9. PubMed ID: 16964430 [Abstract] [Full Text] [Related]
20. Uremia induces functional incompetence of bone marrow-derived stromal cells. Noh H, Yu MR, Kim HJ, Jeon JS, Kwon SH, Jin SY, Lee J, Jang J, Park JO, Ziyadeh F, Han DC, Lee HB. Nephrol Dial Transplant; 2012 Jan 13; 27(1):218-25. PubMed ID: 21622994 [Abstract] [Full Text] [Related] Page: [Next] [New Search]